Israeli Biotech Startup Senseera Offers New Cancer Blood Testing ...
2 days ago · Senseera, an Israeli startup and a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed funding round led by Lightspeed Venture Partners ...
Senseera Raises $7.1 Million Seed Round Led by Lightspeed …
3 days ago · Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed funding round led by Lightspeed Venture Partners, with participation from ...
Senseera secures $7.1m in funding to advance liquid biopsy …
1 day ago · Senseera has closed a seed funding round, securing $7.1m to further develop its GEM BIOMARKERS liquid biopsy platform. Lightspeed Venture Partners led the financing round, with contributions from ...
Senseera Raises $7.1 Million Seed Round Led by Lightspeed
3 days ago · Senseera's technology is built on decades of research led by Prof. Nir Friedman and validated in top-tier journals such as Nature Biotechnology. Supported by data from over 20,000 human samples ...
Israeli biotech Senseera raises $7.1 million Seed round for liquid ...
2 days ago · More news . Recently Read. Why I decided not to become the CEO of the company I founded. ... Jerusalem-based biotech company Senseera has closed a $7.1 million Seed funding round led by Lightspeed Venture Partners, with participation from I-Next Capital and the Lowy Medical Research Institute. The funds will be used to advance the company’s ...
Small Business | The Tribune
3 days ago · Senseera's technology is built on decades of research led by Prof. Nir Friedman and validated in top-tier journals such as Nature Biotechnology. Supported by data from over 20,000 human samples, Senseera has established a robust foundation for accelerating drug development and precision medicine in oncology, immunology, and metabolic diseases ...
Senseera Raises $7.1 Million Seed Round Led by Lightspeed
3 days ago · Senseera's technology is built on decades of research led by Prof. Nir Friedman and validated in top-tier journals such as Nature Biotechnology. Supported by data from over 20,000 human samples ...
Senseera: Liquid Biopsy Company Raises $7.1 Million (Seed)
Senseera’s technology is built on several decades of research led by Prof. Nir Friedman and validated in top-tier journals such as Nature Biotechnology. Supported by data from 20,000+ human samples, Senseera has established a robust foundation for accelerating drug development and precision medicine in oncology, immunology, and metabolic ...
Senseera Raises $7.1M in Seed Funding - finsmes.com
3 days ago · Senseera, a Jerusalem, Israel-based liquid biopsy company, raised $7.1M in Seed funding.. The round was led by Lightspeed Venture Partners, with participation from I-Next Capital and the Lowy ...
Israeli biotech firm secures $7.1m seed funding - Tech in Asia
2 days ago · News Israeli biotech firm secures $7.1m seed funding Israeli biotech firm Senseera has secured US$7.1 million in seed funding, led by Lightspeed Venture Partners with participation from I-Next ...
- Some results have been removed